Overview
Lobbying Costs
1,000,000€ - 1,249,999€
Financial year: Jan 2022 - Dec 2022
Lobbyists (Full time equivalent)
2.9 Fte (11)
Lobbyists with EP accreditation
1
High-level Commission meetings
3
Lobbying Costs over the years
-
Info
Amgen Inc
EU Transparency Register
42243575237-50 First registered on 07 Feb 2011
Goals / Remit
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. Amgen was incorporated in California in 1980 and became a Delaware corporation in 1987. Amgen has a presence in approximately 100 countries worldwide. It operates in one business segment : human therapeutics.
Main EU files targeted
Engage governments and policy makers worldwide on issues important to Amgen to: Ensure patients have access to medicines they need. Provide coverage and reimbursement that reward innovation
Introduce sound, science-based regulation. Enable biotechnology research and development (R&D)Address
Head Office
One Amgen Center Drive
Thousand Oaks, California 91320-1799
UNITED STATESEU Office
5-7 Telecomlaan
Diegem
BELGIUMWebsite
-
People
Total lobbyists declared
11
Employment time Lobbyists 50% 3 25% 4 10% 4 Lobbyists (Full time equivalent)
2.9
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
1 accreditations were / are live (in bold) for the selected state of 24 Mar 2023
Name Start date End Date Ms Viktoria TZOUMA 02 Feb 2023 01 Feb 2024 Ms Marie Helene FANDEL 26 Feb 2019 01 Feb 2020 Mr Douglas GREGORY 24 Jan 2019 24 Jan 2020 Mr Jamie Nathan WILKINSON 20 Nov 2018 20 Nov 2019 Mr Vincent MARTICHOU 27 Mar 2018 30 Mar 2019 Ms Marie Helene FANDEL 16 Feb 2018 16 Feb 2019 Mr Douglas GREGORY 30 Jan 2018 24 Jan 2019 Mr Douglas GREGORY 25 Feb 2017 30 Jan 2018 Ms Marie Helene FANDEL 25 Feb 2017 16 Feb 2018 Mr Janusz LINKOWSKI 05 Sep 2016 26 Aug 2017 Mr Douglas GREGORY 14 Jan 2016 13 Jan 2017 Ms Marie Helene FANDEL 16 Sep 2015 14 Sep 2016 Mr Janusz LINKOWSKI 05 Sep 2015 03 Sep 2016 Ms JOANA MARIA GANDARA LEITAO PAIVA 23 Jan 2015 23 Oct 2015 Mr Douglas GREGORY 23 Jan 2015 14 Jan 2016 Ms JOANA MARIA GANDARA LEITAO PAIVA 15 Mar 2014 23 Jan 2015 Mr Douglas GREGORY 01 Mar 2014 23 Jan 2015 Mr Douglas GREGORY 07 Mar 2013 28 Feb 2014 Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Companies & groups
-
Networking
Affiliation
Amgen is a member of the following organizations in Brussels:
AmCham EU - American Chamber of Commerce to the EU
EFPIA – European Federation of Pharmaceutical Industries and Associations
Eucope - European Confederation of Pharmaceutical Entrepreneurs
EPC - European Policy Centre
Friends of EuropeMember organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2022 - Dec 2022
Lobbying costs for closed financial year
1,000,000€ - 1,249,999€
Major contributions in closed year
None declared
Intermediaries for closed year
Name Amount hanover 100,000€ - 199,999€ hanover 0€ - 10,000€ Intermediaries for current year
Name hanover Closed year Costs
1,000,000€ - 1,249,999€
Other financial info
Higher estimate of annual costs related to activities covered by the register compared to previous financial year is due to:
Increased membership fees to organizations
Increase in percentages of FTEs activity in the scope of the transparency register
Increased representation costs from intermediaries -
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Other activities
None declared
Meetings
Meetings
3 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't publish information about such meetings. All information below comes from European Commission web pages.
-
Date 08 Jul 2022 Location call Subject pharmaceutical supply chains Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Commission - Maurits-Jan Prinz (Cabinet member)
-
Date 12 Jun 2020 Location Videoconference Subject Videoconference CEO of Amgen and CEO of Teneo (Topic: Preparation of Global Pledging Summit on 27 June) Cabinet Cabinet of President Ursula von der Leyen Portfolio President Commission - Ursula von der Leyen (President)
Other Lobbyists -
Date 17 May 2018 Location Brussels Subject Digital Health Cabinet Cabinet of Commissioner Mariya Gabriel Portfolio Digital Economy and Society Commission - Manuel Mateo-Goyet (Cabinet member)